Vt., renewed his criticism of drugmaker Novo Nordisk on Tuesday, claiming that the CEOs of major generic pharmaceutical companies have told him that they can produce and sell its blockbuster diabetes drug Ozempic for less than $100 a month.

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that executives of major generic pharma companies told him they could make generic versions of Ozempic for less than $100 a month.

Senator Bernie Sanders (I-Vt.) once again ramped up pressure on weight loss drugmakers, announcing that he received confirmation from CEOs of major generic drugmakers that Novo Nordisk’s (NVO) blockbuster obesity medicine Ozempic can be sold profitably at $100 per month.